4//SEC Filing
SCHADE CHRISTIAN S 4
Accession 0001104659-22-084772
CIK 0001781983other
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 5:06 PM ET
Size
13.2 KB
Accession
0001104659-22-084772
Insider Transaction Report
Form 4
SCHADE CHRISTIAN S
DirectorPresident & CEO
Transactions
- Award
Stock Option (right to Buy)
2022-07-28+47,600→ 47,600 totalExercise: $1.09Exp: 2032-07-28→ Common Stock (47,600 underlying) - Award
Common Stock
2022-07-28+32,400→ 259,246 total
Holdings
- 1,000(indirect: By Children)
Common Stock
- 1,000(indirect: By Children)
Common Stock
- 1,000(indirect: By Children)
Common Stock
- 1,000(indirect: By Children)
Common Stock
- 1,000(indirect: By Children)
Common Stock
- 1,000(indirect: By Children)
Common Stock
- 5,000(indirect: By Spouse)
Common Stock
Footnotes (3)
- [F1]These shares represent restricted stock units which were granted on July 28, 2022, and which will vest and be settled in common stock on July 28, 2023, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.
- [F2]The option vests in full on July 28, 2023, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.
- [F3]The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, or for any other purpose.
Documents
Issuer
Aprea Therapeutics, Inc.
CIK 0001781983
Entity typeother
Related Parties
1- filerCIK 0001214496
Filing Metadata
- Form type
- 4
- Filed
- Jul 31, 8:00 PM ET
- Accepted
- Aug 1, 5:06 PM ET
- Size
- 13.2 KB